Solid cancer as second malignancy in primary hematological cancer after conventional Treatment- A single institutional study

---

Original Article

Author Details : Sulav Sapkota*, Mona Priyadarshini, Radheshyam Naik

Volume : 6, Issue : 1, Year : 2020

Article Page : 27-31

https://doi.org/10.18231/j.ijmpo.2020.006

Suggest article by email

Get Permission

---

Abstract

Aims: To study the clinico-pathological features of solid cancer as second malignancy in primary hematological cancer after conventional treatment.
Objectives: To study the demographics, treatment and prognosis of solid cancer as second malignancy.
Materials and Methods: It’s a retrospective study conducted over period of nine years in our centre using computer based data base and medical records as the data source from the department of medical oncology and hematology.
Result: Total 5 patients were diagnosed with primary hematological cancers who underwent conventional treatment and later developed second malignancy. Majority of cases were female patient (60%) with mean age of 49.8 years (range 27-72 yrs) diagnosed as primary hematological cancer with advanced stage. Out of 5 patients, only 4 patients (80%) developed solid cancers which included 2 breast cancers,1 cervix cancer and 1 head and neck cancer. Of these four patients, three could be salvaged with conventional treatment while one was lost to follow up.
Conclusion: Solid cancers are one of the rare second malignancies that might occur after conventional treatment in hematological cancers which should be regularly monitored.

Keywords: Solid cancer, Treatment, Hematological cancer.

How to cite : Sapkota S, Priyadarshini M, Naik R, Solid cancer as second malignancy in primary hematological cancer after conventional Treatment- A single institutional study. IP Int J Med Paediatr Oncol 2020;6(1):27-31

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.